Literature DB >> 29297440

Diabetes and poor tuberculosis treatment outcomes: issues and implications in data interpretation and analysis.

P Huangfu1, F Pearson1, C Ugarte-Gil2, J Critchley1.   

Abstract

Tuberculosis (TB) remains one of the 10 leading causes of death worldwide, especially in low- and middle-income countries. We conducted a systematic review and meta-analysis including 88 studies examining the association between diabetes mellitus (DM) and TB treatment outcomes. However, we found several common methodological problems among them, including inappropriate adjustments for confounding factors, not using optimal statistical methods for 'time to event' data, misclassification in exposure (DM) and outcomes (TB treatment outcomes) due to study design and non-standardisation of definitions, misunderstanding of basic study design concept, standardisation of TB treatment outcomes and quality control of publications. Many of these problems would apply more broadly to other 'risk factors' for poor TB treatment outcomes. These issues need to be addressed and resolved to improve the quality of the studies and provide more accurate results for policy makers in the future to tackle the burden of TB.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29297440     DOI: 10.5588/ijtld.17.0211

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  7 in total

1.  Diabetes screen during tuberculosis contact investigations highlights opportunity for new diabetes diagnosis and reveals metabolic differences between ethnic groups.

Authors:  Blanca I Restrepo; Léanie Kleynhans; Alejandra B Salinas; Bassent Abdelbary; Happy Tshivhula; Genesis P Aguillón-Durán; Carine Kunsevi-Kilola; Gloria Salinas; Kim Stanley; Stephanus T Malherbe; Elizna Maasdorp; Moncerrato Garcia-Viveros; Ilze Louw; Esperanza M Garcia-Oropesa; Juan Carlos Lopez-Alvarenga; John B Prins; Gerhard Walzl; Larry S Schlesinger; Katharina Ronacher
Journal:  Tuberculosis (Edinb)       Date:  2018-08-18       Impact factor: 3.131

Review 2.  Stress Hyperglycemia in Patients with Tuberculosis Disease: Epidemiology and Clinical Implications.

Authors:  Matthew J Magee; Argita D Salindri; Nang Thu Thu Kyaw; Sara C Auld; J Sonya Haw; Guillermo E Umpierrez
Journal:  Curr Diab Rep       Date:  2018-08-09       Impact factor: 4.810

3.  The impact of alcohol use on tuberculosis treatment outcomes: a systematic review and meta-analysis.

Authors:  E J Ragan; M B Kleinman; B Sweigart; N Gnatienko; C D Parry; C R Horsburgh; M P LaValley; B Myers; K R Jacobson
Journal:  Int J Tuberc Lung Dis       Date:  2020-01-01       Impact factor: 2.373

4.  Leptospirosis as a risk factor for chronic kidney disease: A systematic review of observational studies.

Authors:  Rodrigo M Carrillo-Larco; Carlos Altez-Fernandez; J Gonzalo Acevedo-Rodriguez; Karol Ortiz-Acha; Cesar Ugarte-Gil
Journal:  PLoS Negl Trop Dis       Date:  2019-05-23

5.  Diabetes, undernutrition, migration and indigenous communities: tuberculosis in Chiapas, Mexico.

Authors:  H A Rashak; H J Sánchez-Pérez; B E Abdelbary; A Bencomo-Alerm; N Enriquez-Ríos; A Gómez-Velasco; A Colorado; M Castellanos-Joya; M H Rahbar; B I Restrepo
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

6.  Diabetes Mellitus and Tuberculosis Treatment Outcomes in Pune, India.

Authors:  Vidya Mave; Sanjay Gaikwad; Madhusudan Barthwal; Ajay Chandanwale; Rahul Lokhande; Dileep Kadam; Sujata Dharmshale; Renu Bharadwaj; Anju Kagal; Neeta Pradhan; Sona Deshmukh; Sachin Atre; Tushar Sahasrabudhe; Shailesh Meshram; Arjun Kakrani; Vandana Kulkarni; Swapnil Raskar; Nishi Suryavanshi; Hardy Kornfeld; Kelly E Dooley; Sandy Chon; Akshay Gupte; Amita Gupta; Nikhil Gupte; Jonathan E Golub
Journal:  Open Forum Infect Dis       Date:  2021-03-04       Impact factor: 4.423

Review 7.  Spatial epidemiology of diabetes: Methods and insights.

Authors:  Diego F Cuadros; Jingjing Li; Godfrey Musuka; Susanne F Awad
Journal:  World J Diabetes       Date:  2021-07-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.